Page 126 - Immunization Practices News Today

As a pediatric nurse who works in one of the few hospitals in the state with a pediatric ICU, I am passionate about protecting the health and well-being of children.

Pfizer Inc.’s vaccine for respiratory syncytial virus received endorsement from a key panel of U.S. advisers for its safety in people 60 and older, a key endorsement for the drugmaker’s potential product.

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

GSKs vaccine for respiratory syncytial virus won the support of a key panel of U.S. regulatory advisers for use in people 60 and older, as the drugmaker races against Pfizer to bring to market the first vaccine for RSV.

Pfizer’s vaccine for respiratory syncytial virus received endorsement from a key panel of U.S. advisers for its safety in people 60 and older, a key endorsement for the drugmaker’s potential

Good evening. I'm Karen Kaplan, and it’s Tuesday, XXX.

Pfizer has confirmed it stopped its clinical trial analyzing COVID-19 vaccine safety and efficacy in pregnant women early. ...

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

Tuesday’s additions bring the states overall totals to 3,057,222 cases and 42,096 deaths since the virus was first detected here in March 2020.

A top U.S. Centers for Disease Control and Prevention (CDC) official gave false information about COVID-19 vaccine safety ...